Form 4: Light & Wonder Director Increases Stake via RSU Vesting
Statement of Changes in Beneficial Ownership
Director Dr. Kneeland Youngblood acquired 2,391 shares following the vesting of restricted stock units and received a new grant of 2,498 units.
Summary
- Dr. Kneeland Youngblood, a Director at Light & Wonder, Inc., processed the vesting of 2,391 Restricted Stock Units (RSUs) on June 10, 2026.
- The vested units converted into 2,391 shares of common stock on a one-for-one basis, held as CHESS Depositary Interests (CDIs) on the Australian Securities Exchange.
- A new award of 2,498 RSUs was granted to the director on June 10, 2026, as part of annual compensation.
- Following these transactions, the director's total direct ownership of common stock increased to 30,555 shares.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive administrative event, confirming continued director commitment and alignment with shareholders through equity ownership.
Positives
- Director maintains a significant equity stake in the company, totaling 30,555 shares of common stock.
- The vesting of previous awards indicates the completion of a service period, suggesting board stability.
- New equity grant of 2,498 units aligns director interests with long-term shareholder value through mid-2027.
Negatives
- The increase in holdings resulted entirely from compensation-related vesting rather than open-market purchases.
Risks
- The filing is a standard administrative disclosure of insider ownership and does not identify specific operational or financial risks.
Future Outlook
The director is scheduled to vest in an additional 2,498 shares by June 2027, contingent on continued service through the 2027 annual meeting of stockholders.
Management Comments
- The reporting person acknowledges that the attorneys-in-fact are not assuming the reporting person's responsibilities to comply with Section 16 of the Exchange Act.
Industry Context
StockSavvy.ai notes that equity-based compensation for directors is a standard practice in the gaming and technology sectors to ensure alignment between board oversight and shareholder interests.
Comparison to Industry Standards
- Light & Wonder's director compensation structure, utilizing RSUs with one-year vesting periods, is consistent with global gaming peers such as Aristocrat Leisure and IGT.
- The use of CHESS Depositary Interests (CDIs) for Australian-listed shares is a standard mechanism for U.S. companies dual-listed or primarily trading on the ASX to facilitate local settlement.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Appointment of Susan Dawson, John Cuddihy, and Sweta Gabhawala as attorneys-in-fact for Section 16 filings. | 2026-06-12 | Administrative update to facilitate efficient regulatory compliance and timely SEC filings. |
Related Party Transactions
- Issuance of 2,498 restricted stock units to Director Dr. Kneeland Youngblood as part of standard director compensation.
Stakeholder Impact
- Shareholders benefit from the continued alignment of director interests with company performance through equity-based compensation.
Next Steps
- Vesting of 2,498 RSUs on or before June 10, 2027.
- Convening of the 2027 Annual Meeting of Stockholders.
Key Dates
| Date | Description |
|---|---|
| 2025-06-10 | Grant date of the restricted stock units that fully vested in this period. |
| 2026-06-10 | Vesting date of 2,391 RSUs and grant date of 2,498 new RSUs. |
| 2026-06-12 | Date of filing and execution of the Power of Attorney. |
| 2027-06-10 | Scheduled vesting date for the newly granted 2,498 RSUs, or the date of the 2027 annual meeting. |
Recommendation
holdThis filing reflects routine compensation-related activity for a director and does not provide new information regarding the company's financial performance or strategic direction that would warrant a change in investment rating.
Keywords
Light & Wonder, LNW, Insider Trading, Form 4, Restricted Stock Units, Kneeland Youngblood, ASX, CDIs, Director Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.